CDMD at ADA Scientific Sessions 2023
Jackie Maupin Jun 16, 2023
Several experts representing the Center for Diabetes and Metabolic Diseases (CDMD) at Indiana University School of Medicine will partake in insightful presentations and showcase their latest findings at the 83rd American Diabetes Association (ADA) Scientific Sessions from June 23-26, 2023, in San Diego, California. Scientific Sessions is the largest scientific meeting focused on diabetes research, prevention, and care. This year, the organization will also recognize Carmella Evans-Molina, PhD, MS, MD, director of the CDMD, with the 2023 Outstanding Scientific Achievement Award.
See the table below for an overview of the CDMD's participation at Scientific Sessions or download it as a PDF. Please keep in mind the times listed are in Pacific Daylight Time. You can also find the conference's full program on the Scientific Sessions website.
Scroll/swipe this table left and right to see more information.
Time (PDT) | Presenter/Contributing Author | Title | Type: Theme/Identifier |
Friday, June 23, 2023 | |||
12:45 - 1:00 PM | Farooq Syed, MSC, PhD | Preclinical Evaluation of TYK2 Inhibitors in Type 1 Diabetes | Oral Presentation: Islet Biology/Insulin Secretion |
12:45 - 1:45 PM | Amelia Linnemann, PhD | Chair: Oral Presentations - Rescuing Islets in Type 1 Diabetes (With ADA Presidents' Select Abstract Presentation) | Oral Presentation: Islet Biology/Insulin Secretion |
1:30 - 1:45 PM | Heba Ismail, MB, BCh, PhD | Loss of Characteristic ß-Cell Function in Autoantibody-Positive (Ab+) Individuals during the Progression to Type 1 Diabetes (T1D) | Oral Presentation: Clinical Diabetes/Therapeutics |
3:00 - 3:15 PM | Becca Davison, PhD, MS | Swi/Snf Controls Transcriptional Programs Required for ß-Cell Development and Postnatal Islet Function | Oral Presentation: Islet Biology/Insulin Secretion |
Saturday, June 24, 2023 | |||
8:00 - 9:00 AM | Tamara Hannon, MD | New Onset Diabetes in Adolescents--Is it Type 1, Type 2, or Another Type? | Symposium: Clinical Diabetes/Therapeutics |
11:30 AM - 12:30 PM | Mary de Groot, PhD | Symptoms of Autonomic Nervous System Dysregulation and Diabetes Distress in T2D Adults | Poster Session: 628-P |
11:30 AM - 12:30 PM | Mary de Groot, PhD | Health Disparities among People With and Without Diabetes during 24 Monthso f the COVID-19 Pandemic | Poster Session: 635-P |
11:30 AM - 12:30 PM | Emily K. Sims, MD, MS | Single Islet Antigen 2 Antibody-Positive (IA2A Ab+) Children Exhibit Significant Metabolic Abnormalities and 5-Year Type 1 Diabetes (T1D) Risk | Poster Session: 1440-P |
11:30 AM - 12:30 PM | Emily K. Sims, MD, MS | Index60 Stratification Enhances Current Staging for Type 1 Diabetes by Identifying At-Risk Single Islet Autoantibody Positive (Ab+) Individuals | Poster Session: 1441-P |
11:30 AM - 12:30 PM | Emily K. Sims, MD, MS | The Effect of Abatacept upon Glucose and C-Peptide Endpoints at One Year of Treatment and on Follow-up | Poster Session: 731-P |
11:30 AM - 12:30 PM | Staci Weaver | Loss of SERCA2 Induces Mitochondrial Dysfunction, Increases ß-Cell Senescence, and Accelerates Type 1 Diabetes Development | Poster Session: 296-LB |
11:30 AM - 12:30 PM | Wenting Wu, PhD | Heterogeneity of Single Cells Obtained from Peripheral Blood Mononuclear Cells Collected from Youth with Recent-Onset Type 1 Diabetes | Poster Session: 217-LB |
11:50 AM - 12:05 PM | Carmella Evans-Molina, MD, PhD | Trouble in the Neighborhood--Emerging Roles for Beta-Cell miRNAs in Type 1 Diabetes Pathogenesis and Risk Stratification | Professional Interest Group Discussion: Islet Biology/Insulin Secretion |
12:30 - 12:40 PM | Christopher J. Contreras, PhD | RIPK1 Promotes Thapsigargin-Induced β-Cell Death Independent of Caspase 3/7 Activity in Vitro | ePoster Theater: Islet Biology/Insulin Secretion 1722-P |
3:27 - 3:39 PM | Linda DiMeglio, MD, MPH | Consortia Representative: Panel Discussion - The New Normal--Perspectives on Treatment and Trials as Immunotherapies Enter the Type 1 Diabetes Clinical Landscape | Panel Discussion: Immunology/Beta-Cell Replacement |
4:30 - 6:00 PM | Amelia Linnemann, PhD | Chair: Oral Presentations - Insulin Secretion | Oral Presentation: Islet Biology/Insulin Secretion |
4:50 - 5:10 PM | Heba Ismail, MB, BCh, PhD | Precision Medicine in Type 1 Diabetes | Symposium: Clinical Diabetes/Therapeutics |
4:45 - 5:00 PM | Maddie McLaughlin | STIM1 Interacts with G Protein-Coupled Estrogen Receptor Signaling to Maintain ß-Cell Identity in Female Mice | Oral Presentation: Islet Biology/Insulin Secretion |
Sunday, June 25, 2023 | |||
11:30 AM - 12:30 PM | Jonathan Flak, PhD | Ventromedial Hypothalamic Nucleus Subset Stimulates Tissue Thermogenesis via Preoptic Outputs | Poster Session: 1525-P |
12:00 - 12:10 PM | Staci Weaver | Loss of SERCA2 Induces Mitochondrial Dysfunction, Increases ß-Cell Senescence, and Accelerates Type 1 Diabetes Development | ePoster Theater: Obesity/Integrated Physiology 296-LB |
12:30 -1:30 PM | Jason Spaeth, PhD | Discussion Moderator: ePoster Theater - Islet Biology Potpourri | ePoster Theater: Islet Biology/Insulin Secretion |
Monday, June 26, 2023 | |||
8:00 - 9:30 AM | Andrew Templin, PhD | Novel Insights into Tumor Necrosis Factor (TNF) Receptor Signaling and Beta-Cell Death | Symposium: Islet Biology/Insulin Secretion |
9:45 - 11:15 AM | Carmella Evans-Molina, MD, PhD | National Scientific & Health Care Achievement Awards Presentation | Special Lectures and Addresses |
10:15 - 11:15 AM | Carmella Evans-Molina, MD, PhD | Outstanding Scientific Achievement Award Lecture: The Ailing Beta Cell in Diabetes--Insights from a Trip to the ER | Special Lectures and Addresses |
11:30 AM - 12:30 PM | Renato C.S. Branco, PhD | The Role of MiR-146a-5p on Cytokine-Induced β-Cell Mitochondrial Dysfunction and Death | Poster Session: 1725-P |
11:30 AM - 12:30 PM | Christopher J. Contreras, PhD | RIPK1 Promotes Thapsigargin-Induced β-Cell Death Independent of Caspase 3/7 Activity in Vitro | Poster Session: 1722-P |
11:30 AM - 12:30 PM | Linda DiMeglio, MD, MPH | Promoting Career Development of Physicians Engaged in Type 1 Diabetes (T1D) Research—The New DiabDocs Multicenter National K12 Program | Poster Session: 1162-P |
11:30 AM - 12:30 PM | Mary de Groot, PhD | Discussion Moderator: ePoster Theater - Targets for Psychosocial Research and Care in Diabetes--From Brains and Behavior to Public Health | ePoster Theater: Behavioral Medicine/Clinical Nutrition/Education and Exercise |
11:30 AM - 12:30 PM | Maryalice Hartley | SERCA2 Regulates ER Lipid Composition and Proinsulin Processing | Poster Session: 1751-P |
11:30 AM - 12:30 PM | Heba Ismail, MB, BCh, PhD | Gut Microbial Differences in Youth with Obesity and Type 1 Diabetes (T1D) | Poster Session: 1131-P |
11:30 AM - 12:30 PM | Sukrati Kanojia | Evaluating the role of Chd3 helicase subunit on β-cell function | Poster Session: 1733-P |
11:30 AM - 12:30 PM | Tatsuyoshi Kono, MSC, PhD | STIM1 Maintains Beta-Cell Identity and Function | Poster Session: 1771-P |
11:30 AM - 12:30 PM | Noyonika Mukherjee | Caspase 3/7 Activation and RIPK3 Are Dispensable for Synthetic hIAPP-Induced ß-Cell Death | Poster Session: 1724-P |
12:10 - 12:20 PM | Mary de Groot, PhD | Symptoms of Autonomic Nervous System Dysregulation and Diabetes Distress in T2D Adults | ePoster Theater: Behavioral Medicine/Clinical Nutrition/Education and Exercise 628-P |
2:30 - 3:00 PM | Lim Kua, MD | Sex Differences in the Beta-Cell Response to Maternal Obesity | Symposium: Islet Biology/Insulin Secretion |
The views expressed in this content represent the perspective and opinions of the author and may or may not represent the position of Indiana University School of Medicine.

Jackie Maupin
Jackie supports the Herman B Wells Center for Pediatric Research at IU School of Medicine. As communications generalist, Jackie helps spread the word about the Wells Center's commitment to improving the health of children in Indiana and beyond through basic and translational research. She has several years of experience in non-profit and academic marketing and communications.